- Home
- Publications
- Publication Search
- Publication Details
Title
Investigational drugs for the treatment of cervical cancer
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 26, Issue 4, Pages 389-402
Publisher
Informa UK Limited
Online
2017-03-09
DOI
10.1080/13543784.2017.1302427
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biological implications and therapeutic significance of DNA methylation regulated genes in cervical cancer
- (2016) Samatha Bhat et al. BIOCHIMIE
- A phase I study of mTOR inhibitor everolimus in association with cisplatin and radiotherapy for the treatment of locally advanced cervix cancer: PHOENIX I
- (2016) Andréia Cristina de Melo et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Prevention of cervical cancer: journey to develop the first human papillomavirus virus-like particle vaccine and the next generation vaccine
- (2016) Janine T Bryan et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Global strategies for cervical cancer prevention
- (2016) Sharmila Pimple et al. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- A first-in-human phase I study of the oral Notch inhibitor, LY900009, in patients with advanced cancer
- (2016) Shubham Pant et al. EUROPEAN JOURNAL OF CANCER
- Bevacizumab for the treatment of cervical cancer
- (2016) Nicolò Bizzarri et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Effect and Safety of Recombinant Adenovirus-p53 Transfer Combined with Radiotherapy on Long-Term Survival of Locally Advanced Cervical Cancer
- (2016) Xing Su et al. HUMAN GENE THERAPY
- Sorafenib Increases Tumor Hypoxia in Cervical Cancer Patients Treated With Radiation Therapy: Results of a Phase 1 Clinical Study
- (2016) Michael F. Milosevic et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research
- (2016) Sung-Jong Lee et al. Journal of Gynecologic Oncology
- Advances in diagnosis and treatment of metastatic cervical cancer
- (2016) Haoran Li et al. Journal of Gynecologic Oncology
- Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810
- (2016) Gerald S. Falchook et al. Journal for ImmunoTherapy of Cancer
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A pilot study of nimotuzumab plus single agent chemotherapy as second- or third-line treatment or more in patients with recurrent, persistent or metastatic cervical cancer
- (2015) Lucely Cetina et al. CANCER BIOLOGY & THERAPY
- A Phase I-II Evaluation of Veliparib (NSC #737664), Topotecan, and Filgrastim or Pegfilgrastim in the Treatment of Persistent or Recurrent Carcinoma of the Uterine Cervix
- (2015) Charles Kunos et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505
- (2015) Ryo Kitagawa et al. JOURNAL OF CLINICAL ONCOLOGY
- Complete Regression of Metastatic Cervical Cancer After Treatment With Human Papillomavirus–Targeted Tumor-Infiltrating T Cells
- (2015) Sanja Stevanović et al. JOURNAL OF CLINICAL ONCOLOGY
- Cediranib combined with carboplatin and paclitaxel in patients with metastatic or recurrent cervical cancer (CIRCCa): a randomised, double-blind, placebo-controlled phase 2 trial
- (2015) R Paul Symonds et al. LANCET ONCOLOGY
- Phase 2 trial of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced cervical cancer
- (2014) Angelica Nogueira-Rodrigues et al. CANCER
- mTOR inhibitors and their clinical application in cervical, endometrial and ovarian cancers: A critical review
- (2014) Nader Husseinzadeh et al. GYNECOLOGIC ONCOLOGY
- Improved Survival with Bevacizumab in Advanced Cervical Cancer
- (2014) Krishnansu S. Tewari et al. NEW ENGLAND JOURNAL OF MEDICINE
- HPV vaccines to prevent cervical cancer and genital warts: an update
- (2014) Carine Dochez et al. VACCINE
- Long-Term Disease Control with Triapine-Based Radiochemotherapy for Patients with Stage IB2–IIIB Cervical Cancer
- (2014) Charles A. Kunos et al. Frontiers in Oncology
- A pilot feasibility study for cisplatin plus S-1 for the treatment for advanced or recurrent cervical cancer
- (2013) Mayu Yunokawa et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cisplatin Resistance Associated with PARP Hyperactivation
- (2013) J. Michels et al. CANCER RESEARCH
- The surgical management of early-stage cervical cancer
- (2013) Sabina R. Salicrú et al. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix. A trial of the NCIC Clinical Trials Group (NCIC CTG IND 199)
- (2013) A.V. Tinker et al. GYNECOLOGIC ONCOLOGY
- Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer
- (2013) Israel Zighelboim et al. GYNECOLOGIC ONCOLOGY
- Role of Gefitinib in Patients With Recurrent or Metastatic Cervical Carcinoma Ineligible or Refractory to Systemic Chemotherapy
- (2013) Daya Nand Sharma et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Landscape of genomic alterations in cervical carcinomas
- (2013) Akinyemi I. Ojesina et al. NATURE
- ADXS11-001 immunotherapy targeting HPV-E7: updated survival and safety data from a phase 2 study in Indian women with recurrent/refractory cervical cancer
- (2013) Robert G Petit et al. Journal for ImmunoTherapy of Cancer
- The Role of PARP Inhibitors in the Treatment of Gynecologic Malignancies
- (2013) Raquel E. Reinbolt et al. Frontiers in Oncology
- Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: A gynecologic oncology group study
- (2012) David S. Alberts et al. GYNECOLOGIC ONCOLOGY
- PI3K/AKT/mTOR Inhibitors in Patients With Breast and Gynecologic Malignancies HarboringPIK3CAMutations
- (2012) Filip Janku et al. JOURNAL OF CLINICAL ONCOLOGY
- Aberrant DNA methylation in cervical carcinogenesis
- (2012) Hui-Juan Yang Chinese Journal of Cancer
- Epidermal growth factor receptor as a biomarker for cervical cancer
- (2011) T. Soonthornthum et al. ANNALS OF ONCOLOGY
- Phase II study of S-1, an oral fluoropyrimidine, in patients with advanced or recurrent cervical cancer
- (2011) N. Katsumata et al. ANNALS OF ONCOLOGY
- Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: A Gynecologic Oncology Group study
- (2011) John Farley et al. GYNECOLOGIC ONCOLOGY
- Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
- (2011) Alessandro D. Santin et al. GYNECOLOGIC ONCOLOGY
- Phase II Trial of Capecitabine and Cisplatin in Advanced, Persistent, or Recurrent Carcinoma of the Cervix
- (2011) Hassan Errihani et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Cetuximab monotherapy in advanced cervical cancer: a retrospective study with five patients
- (2010) Linda Hertlein et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- MK-1775, a small molecule Wee1 inhibitor, enhances anti-tumor efficacy of various DNA-damaging agents, including 5-fluorouracil
- (2010) Hiroshi Hirai et al. CANCER BIOLOGY & THERAPY
- Phase I Trial of Pelvic Radiation, Weekly Cisplatin, and 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, NSC #663249) for Locally Advanced Cervical Cancer
- (2010) C. A. Kunos et al. CLINICAL CANCER RESEARCH
- Locally advanced cervical cancer: what is the standard of care?
- (2010) Zeina Al-Mansour et al. CURRENT OPINION IN ONCOLOGY
- Activation of mTOR signaling pathway contributes to survival of cervical cancer cells
- (2010) Jing Ji et al. GYNECOLOGIC ONCOLOGY
- A phase I study of weekly temsirolimus and topotecan in the treatment of advanced and/or recurrent gynecologic malignancies
- (2010) Sarah M. Temkin et al. GYNECOLOGIC ONCOLOGY
- Lack in Efficacy for Imatinib Mesylate as Second-Line Treatment of Recurrent or Metastatic Cervical Cancer Expressing Platelet-Derived Growth Factor Receptor α
- (2010) Myrna Candelaria et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- A Phase II Trial of Erlotinib in Recurrent Squamous Cell Carcinoma of the Cervix
- (2010) Russell J. Schilder et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Phase II, Open-Label Study of Pazopanib or Lapatinib Monotherapy Compared With Pazopanib Plus Lapatinib Combination Therapy in Patients With Advanced and Recurrent Cervical Cancer
- (2010) Bradley J. Monk et al. JOURNAL OF CLINICAL ONCOLOGY
- High expression of mTOR is associated with radiation resistance in cervical cancer
- (2010) Min-Kyu Kim et al. Journal of Gynecologic Oncology
- A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results
- (2010) Jaime Coronel et al. MEDICAL ONCOLOGY
- Ribonucleotide Reductase Inhibition Enhances Chemoradiosensitivity of Human Cervical Cancers
- (2010) Charles A. Kunos et al. RADIATION RESEARCH
- Evaluation of pemetrexed (Alimta, LY231514) as second-line chemotherapy in persistent or recurrent carcinoma of the cervix: the CERVIX 1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group
- (2009) D. Lorusso et al. ANNALS OF ONCOLOGY
- Cetuximab, topotecan and cisplatin for the treatment of advanced cervical cancer: A phase II GINECO trial
- (2009) J.E. Kurtz et al. GYNECOLOGIC ONCOLOGY
- A phase II study of sunitinib in patients with locally advanced or metastatic cervical carcinoma: NCIC CTG Trial IND.184
- (2009) Helen J. Mackay et al. GYNECOLOGIC ONCOLOGY
- Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium
- (2009) Sergio Pecorelli INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study
- (2009) Bradley J. Monk et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Bevacizumab in the Treatment of Persistent or Recurrent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study
- (2009) Bradley J. Monk et al. JOURNAL OF CLINICAL ONCOLOGY
- Replication and Assembly of Human Papillomaviruses
- (2009) M.J. Conway et al. JOURNAL OF DENTAL RESEARCH
- Phase I Trial of Erlotinib Combined with Cisplatin and Radiotherapy for Patients with Locally Advanced Cervical Squamous Cell Cancer
- (2008) A. Nogueira-Rodrigues et al. CLINICAL CANCER RESEARCH
- Evaluation of pemetrexed (Alimta, LY231514) as second line chemotherapy in persistent or recurrent carcinoma of the cervix: A Phase II study of the Gynecologic Oncology Group
- (2008) David Scott Miller et al. GYNECOLOGIC ONCOLOGY
- High-Grade Cervical Dysplasia: Pathophysiology, Diagnosis, and Treatment
- (2008) Meggan Zsemlye OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA
- A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer
- (2007) A. Goncalves et al. GYNECOLOGIC ONCOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started